Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

Marie Skłodowska-Curie Action · Running

AUREUS wAll teichoic acids as immUnogenic and conseRved altErnative targets for therapies versUs S. aureus

Coordinator
Universita Degli Studi Di Napoli Federico Ii, Italy
Runs
1 February 2025 to 31 January 2029
Status
Running
EU funding
€3.5m
Total cost
—
Partners
18 organisations in 8 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101168287

What the project is doing

In the project's own words, from its summary on CORDIS.

The AUREUS doctoral network meets the increasing need of a highly qualified work force to counteract multidrug-resistant S. aureus infections by performing cutting-edge, inter-disciplinary research in the multifaceted field of chemical biology. The proposed research program aims at training Doctoral Candidates (DCs) to acquire complementary skills to exploit and develop different and innovative strategies to i) unveil the biosynthesis and structure of unique S. aureus cell wall glycopolymers, the so-called WTA (wall teichoic acids), ii) gain greater insights into the molecular basis of the human immune responses to S. aureus WTA, iii) harness the acquired knowledge to rationally design and develop effective immune-based therapies against S. aureus and related bacterial species.

To this end, the AUREUS intersectoral program is based on a unique international team combining expertise in different fields including chemistry, (micro-)biology and immunology. In detail, 9 world academic leaders in the glycoscience and/or S. aureus research world and 4 companies (SMEs) with world-class expertise in glycoscience, cutting-edge diagnostics and therapeutic research programs will be involved in the AUREUS project.

Each DC will have their own individual project, based on fundamental science and with practical applications, either in biotechnology or in biomedicine, as will be explored through secondments with our industrial partners. The AUREUS network will provide 14 young scientists with broad, top-class scientific and professional competences and skills, thereby expanding the pipeline of future leaders for both industry and academia.

Who is involved

OrganisationCityCountryRole
Universita Degli Studi Di Napoli Federico IiNapoliItalyCoordinator
Universitat WienWienAustriaParticipant
Eberhard Karls Universitaet TuebingenTuebingenGermanyParticipant
Agencia Estatal Consejo Superior De Investigaciones CientificasMadridSpainParticipant
Universidad Autonoma De MadridMadridSpainAssociatedpartner
GlycodiagChevillyFranceParticipant
Universite D'orleansOrleans Cedex 2FranceAssociatedpartner
Universite Grenoble AlpesGrenobleFranceParticipant
National Institute for Bioprocessing Research and Training LimitedBlackrock DublinIrelandParticipant
University College Dublin, National University of Ireland, DublinDublinIrelandAssociatedpartner
Biopox SRLNapoliItalyAssociatedpartner
Innovation Acta SRLSienaItalyAssociatedpartner
Stichting Amsterdam UmcAmsterdamNetherlandsParticipant
Universiteit LeidenLeidenNetherlandsParticipant
Universiteit Van AmsterdamAmsterdamNetherlandsAssociatedpartner
Iceni Glycoscience LimitedColchesterUnited KingdomAssociatedpartner
Imperial College of Science Technology and MedicineLondonUnited KingdomAssociatedpartner
University of YorkYork North YorkshireUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI